No takes yet. Share an insight, caveat, or question.
Observational study finds apixaban reduces overall bleeding in patients with venous thromboembolism and cancer, indicating risks differ among treatments.
Brodin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: